Drug Reference
Vemurafenib
B-Raf serine-threonine kinase (BRAF) inhibitors
Fact box
- Therapeutic class
- B-Raf serine-threonine kinase (BRAF) inhibitors
- Action class
- Kinase Inhibitor
- Mechanism
- Protein Kinase Inhibitors
- Habit forming
- No
Brand names
Zelboraf
Available as
240 MG · Oral Tablet
No structured FDA label was available. Use the authoritative links below.
Authoritative sources
Reference only — not clinical advice. Verify against current FDA labeling and consult a licensed provider. About half of pediatric drug use is off-label and is not reflected in FDA labels; absence of pediatric information does not mean a medicine is unused or unsafe in children.